The influence of economic incentives and regulatory factors on the adoption of treatment technologies: A case study of technologies used to treat heart attacks

Health Economics

Volumn 18, Issue 10, 2009, Pages 1114-1132

  Bech, Mickael ^a   Christiansen, Terkel ^a   Dunham, Kelly ^b   Lauridsen, Jørgen ^a   Lyttkens, Carl Hampus ^c   Mcdonald, Kathryn ^b   Mcguire, Alistair ^d   Hobbs, Michael ^e   Ridout, Steve ^e   Richardson, Jeff ^f   Robertson, Iain ^f   Closon, Marie Christine ^g   Perelman, Julian ^g   Fassbender, Konrad ^h   Tu, Jack ⁱ   Grant, Curry ⁱ   Austin, Peter C ⁱ   Pilote, Louise ^j   Eisenberg, Mark J ^k   Richard, Hugues ^l   Madsen, Mette ^m   Rasmussen, Søren ^m   Abildstrom, Steen Z ^m   Goldacre, Michael ⁿ   Yeates, David ⁿ   Robinson, Michael ^o   Keskimäki, Ilmo ^p   Häkkinen, Unto ^p   Salomaa, Veikko ^p   Mähönen, Markku ^p   Dormont, Brigitte ^q   Milcent, Carine ^r   Durand Zaleski, Isabelle ^s   Gerhardus, Ansgar ^t   Walelu, Okyta Á ^t   Grobe, Thomas ^t   Krauth, Christian ^t   Schwartz, Friedrich Wilhelm ^t   Loewel, Hannelore ^u   Hoermann, Allmut ^u   Meisinger, Christa ^u   Heier, Margit ^u   Gordon, Ethel Sherry ^v   Haklai, Ziona ^v   Kark, Jeremy D ^w   Shmueli, Amir ^w   Atella, Vincenzo ^x   Fabbri, Daniele ^y   Vanuzzo, Diego ^z   Pilotto, Lorenza ^z   Pilotto, Laura ^z   Imanaka, Yuichi ^aa   Ishizaki, Tatsuro ^aa   Kaneko, Yoshihiro ^ab   Noguchi, Haruko ^ac   Kim, Young Hoon ^ad   Yang, Bong Min ^ae   Roh, Yong Kyun ^af   Cho, Kyung Hwan ^ad   Lee, Hong Soon ^ag   Haug, Charlotte ^ah   Raikou, Maria ^d   Windmeijer, Frank ^ai   Boyd, James ^aj   Mak, Koon Hou ^ak   Kai, Hong Phua ^ak   Ng, Tze Pin ^ak   Ling, Ling Sim ^ak   Chew, Suok Kai ^ak   Tan, Caren ^ak   Dozet, Alexander ^c   Höjgård, Sören ^c   Lindgren, Anna ^c   Öhlin, Hans ^c   Paccaud, Fred ^al   Burnand, Bernard ^al   Wietlisbach, Vincent ^al   Holly, Alberto ^am   Gardiol, Lucien ^am   Eggli, Yves ^am   Lai, Mei Shu ^an   Lo, Joan C ^ao   Heidenreich, Paul ^b   Kessler, Daniel ^b   McClellan, Mark ^b   Moreland, Abigail ^b   Saynina, Olga ^b   Newhouse, Joseph ^ap   more..

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b STANFORD UNIVERSITY   (United States)

^c LUND UNIVERSITY   (Sweden)

^d LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^j MONTREAL GENERAL HOSPITAL   (Canada)

^k MCGILL UNIVERSITY   (Canada)

^l MCGILL UNIVERSITY   (Canada)

^m UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o Nuffield Institute for Health   (United Kingdom)

^p NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^q UNIVERSITÉ PARIS DAUPHINE   (France)

^r CNRS   (France)

^s HENRI MONDOR HOSPITAL   (France)

^t HANNOVER MEDICAL SCHOOL   (Germany)

^u INSTITUTE OF EPIDEMIOLOGY   (Germany)

^v MINISTRY OF HEALTH   (Israel)

^w HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^x UNIVERSITY OF ROME TOR VERGATA   (Italy)

^y UNIVERSITY OF BOLOGNA   (Italy)

^z Centro Malattie Cardiovascolari   (Italy)

^aa KYOTO UNIVERSITY   (Japan)

^ab NATIONAL INSTITUTE OF POPULATION AND SOCIAL SECURITY RESEARCH   (Japan)

^ac Toyo Eiwa University   (Japan)

^ad Korea University Ansan Hospital   (South Korea)

^ae Seoul National University   (South Korea)

^af Hallym University   (South Korea)

^ag National Medical Center   (South Korea)

^ah Hallym University ^*  (Norway)

^ai UNIVERSITY OF BRISTOL   (United Kingdom)

^aj Scottish Home and Health Department   (United Kingdom)

^ak DEPARTMENT OF CARDIOLOGY   (Singapore)

^al UNIVERSITY OF LAUSANNE   (Switzerland)

^am UNIVERSITY OF LAUSANNE   (Switzerland)

^an Bureau of National Health Insurance Taiwan   (Taiwan)

^ao INSTITUTE OF ECONOMICS   (Taiwan)

^ap HARVARD UNIVERSITY   (United States)

more..

Author keywords

Diffusion of technologies; Economic incentives and regulation; Technological change

Indexed keywords

ARTICLE; CASE STUDY; CORONARY ARTERY BYPASS GRAFT; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; INCOME; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; REIMBURSEMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

DEVELOPED COUNTRIES; DIFFUSION OF INNOVATION; HUMANS; MYOCARDIAL ISCHEMIA; ORGANIZATIONAL CASE STUDIES; REIMBURSEMENT, INCENTIVE; TECHNOLOGY, MEDICAL;

EID: 70350767547     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1417     Document Type: Article

References (36)

1. Australian Productivity Commission. 2005. Impacts of Advances in Medical Technology in Australia. Australian Productivity Commission: Melbourne.
2. Barros PP. 1998. The black box of health care expenditure growth determinants. Health Economics 7(6): 165-181.
3. Bech M, Christiansen T, Dunham K, Lauridsen J, Lyttkens CH, McDonald K, McGuire A. 2006. How do economic incentives and regulatory factors influence adoption of cardiac technologies? Result from the TECH project. Working Paper No. 2006:15, Department of Economics, Lund University.
4. Congressional Budget Office. 2008. Technological Change and the Growth of Health Care Spending. Congressional Budget Office, Congress of the USA: Washington, DC.
5. Cutler DM, Huckman RS. 2003. Technological development and medical productivity: the diffusion of angioplasty in New York state. Journal of Health Economics 22(2): 187-217.
6. Cutler DM, McClellan M. 1998. What is technological change?. In Inquiries in the Economics of Aging, Wise DA (ed.). University of Chicago Press: Chicago, IL; 51-81.
7. Cutler DM, McClellan M, Newhouse JP. 1998a. What has increased medical-care spending bought? American Economic Review 88(2): 132-136.
8. Cutler DM, McClellan MB. 1996. The determinants of technological change in heart attack treatment. NBER Working Paper No. w5751.
9. Cutler DM, McClellan MB, Newhouse JP, Remler D. 1998b. Are medical prices declining? Evidence for heart attack treatment. Quarterly Journal of Economics 113(4): 991-1024. (Pubitemid 128161439)
10. Dickson M, Jacobzone S. 2003. Pharmaceutical use and expenditure for cardiovascular disease and stroke: a study of 12 OECD Countries. Health working papers, OECD.
11. Escarce J. 1996. Externalities in hospitals and physician adoption of a new surgical technology: an exploratory analysis. Journal of Health Economics 15(6): 715-734. (Pubitemid 27086530)
12. Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A. 2002. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. British Journal of Haematology 117(2): 451-468. (Pubitemid 34451165)
13. Gerdtham U-G, Jö nsson B. 2000. International comparison of health expenditure: theory, data and econometric analysis. In Handbook of Health Economics, Culyer AJ, Newhouse JP (eds). Elsevier: Amsterdam; 11-53.
14. Greenberg D, Peiser JG, Peterburg Y, Pliskin JS. 2001. Reimbursement policies, incentives and disincentives to perform laparoscopic surgery in Israel. Health Policy 56(1): 49-63. (Pubitemid 32166755)
15. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. 2003. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. Journal of the American College of Cardiology 41(8): 1293-1304.
16. Hurst JW. 1991. Reforming health care in seven European nations. Health Affairs 10(3): 7-21.
17. Lazaro P, Fitch K. 1995. The distribution of big ticket medical technologies in Oecd countries. International Journal of Technology Assessment in Health Care 11(3): 552-570.
18. McClellan M, Kessler DP. 1999. A global analysis of technological change in health care: the case of heart attacks. Health Affairs 18(3): 250-255.
19. McClellan MB, Kessler DP. 2002. Technological Change in Health Care - A Global Analysis of Heart Attack. The University of Michigan Press: Ann Arbor, MI.
20. Mcpherson K, Wennberg JE, Hovind OB, Clifford P. 1982. Small-area variations in the use of common surgicalprocedures - an international comparison of New-England, England, and Norway. New England Journal of Medicine 307(21): 1310-1314.
21. Moïse P. 2003a. The heart of the health care system: summary of the ischaemic heart disease part of the OECD ageing-related diseases study. A Disease-based Comparison of Health Systems: What is Best and at What Cost? OECD: Paris; 27-52.
22. Moïse P. 2003b. The technology-health expenditure link: a perspective from the ageing-related diseases study. A Disease-based Comparison of Health Systems: What is Best and at What Cost? OECD: Paris; 195-218.
23. Newhouse JP. 1992. Medical care costs: how much welfare loss?. Journal of Economic Perspectives 6(3): 3-21.
24. Nystedt P, Lyttkens CH. 2003. Age diffusion never stops? Carotid endarterectomy among the elderly. Applied Health Economics and Health Policy 2(1): 3-7.
25. OECD. 1994. The reform of health care systems - a review of seventeen OECD countries. Health Policy Studies (5th edn). OECD: Paris.
26. Oh EH, Imanaka Y, Evans E. 2005. Determinants of the diffusion of computed tomography and magnetic resonance imaging. International Journal of Technology Assessment in Health Care 21(1): 73-80. (Pubitemid 40229371)
27. Okunade AA, Miles AP. 1999. Medicare physician payment reform and the utilization of cardiovascular procedures. Journal of Health and Social Policy 11(1): 37-52.
28. Okunade AA, Murthy VNR. 2002. Technology as a 'major driver' of health care costs: a cointegration analysis of the Newhouse conjecture. Journal of Health Economics 21(1): 147-159.
29. Pestieau P. 2006. The Welfare State in the European Union: Economic and Social Perspectives. Oxford University Press: Oxford.
30. Rublee DA. 1989. Medical technology in Canada, Germany, and the United-States. Health Affairs 8(3): 178-181.
31. Rublee DA. 1994. Medical technology in Canada, Germany, and the United-States - an update. Health Affairs 13(4): 113-117.
32. Scherer FM. 2000. The pharmaceutical industry. In Handbook of Health Economics, Culyer AJ, Newhouse JP (eds), vol.1b. Elsevier, North-Holland: Amsterdam; 1197-1236.
33. Slade EP, Anderson GF. 2001. The relationship between per capita income and diffusion of medical technologies. Health Policy 58(1): 1-14.
34. Tech Research Network. 2001. Technological change around the world: evidence from heart attack care. Health Affairs 20(3): 25-42.
35. Van Den Brand M, The European Angioplasty Survey Group. 1993. Utilization of coronary angioplasty and cost of angioplasty disposables in 14 Western-European countries. European Heart Journal 14(3): 391-397.
36. Weisbrod BA. 1991. The health care quadrilemma: an essay on technological change, insurance, quality of care, and cost containment. Journal of Economic Literature 29(2): 523-552.